Form 8-K - Current report:
SEC Accession No. 0001104659-21-132980
Filing Date
2021-11-02
Accepted
2021-11-02 16:01:13
Documents
3
Period of Report
2021-10-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131671d1_8k.htm 8-K 22683
2 EXHIBIT 3.1 tm2131671d1_ex3-1.htm EX-3.1 36126
3 EXHIBIT 3.2 tm2131671d1_ex3-2.htm EX-3.2 150108
  Complete submission text file 0001104659-21-132980.txt   210115
Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 211371085
SIC: 2834 Pharmaceutical Preparations